133 related articles for article (PubMed ID: 1834742)
1. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
Levine BL; May WS; Tyler PG; Hess AD
J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor/CD3 complex internalization following activation of a cytolytic T cell clone: evidence for a protein kinase C-independent staurosporine-sensitive step.
Boyer C; Auphan N; Luton F; Malburet JM; Barad M; Bizozzero JP; Reggio H; Schmitt-Verhulst AM
Eur J Immunol; 1991 Jul; 21(7):1623-34. PubMed ID: 1829410
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
Basu A; Lazo JS
Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725
[TBL] [Abstract][Full Text] [Related]
5. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
[TBL] [Abstract][Full Text] [Related]
6. A protein kinase C-activating phorbol ester accelerates the T cell antigen receptor-stimulated phosphatidylinositol cycle in normal human CD4+ T cells.
Whelan JP; Shearer WT; Gilliam EB; Hardy KJ
J Immunol; 1992 May; 148(9):2872-8. PubMed ID: 1349321
[TBL] [Abstract][Full Text] [Related]
7. Selection and preliminary characterization of variant lines of a murine macrophage tumor resistant to the antiproliferative effects of phorbol esters.
Goode NT; Moore JP; Hart IR
Cancer Res; 1990 Mar; 50(5):1510-5. PubMed ID: 2105841
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C.
Nel AE; Hanekom C; Rheeder A; Williams K; Pollack S; Katz R; Landreth GE
J Immunol; 1990 Apr; 144(7):2683-9. PubMed ID: 2156931
[TBL] [Abstract][Full Text] [Related]
9. Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation.
Arita Y; O'Driscoll KR; Weinstein IB
Cancer Res; 1992 Aug; 52(16):4514-21. PubMed ID: 1643643
[TBL] [Abstract][Full Text] [Related]
10. Phorbol ester synergizes with Ca2+ ionophore in activation of protein kinase C (PKC)alpha and PKC beta isoenzymes in human T cells and in induction of related cellular functions.
Altman A; Mally MI; Isakov N
Immunology; 1992 Jul; 76(3):465-71. PubMed ID: 1388136
[TBL] [Abstract][Full Text] [Related]
11. Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
Esa AH; Boto WO; Adler WH; May WS; Hess AD
Int J Immunopharmacol; 1990; 12(5):481-90. PubMed ID: 2210911
[TBL] [Abstract][Full Text] [Related]
12. An intracellular calcium increase and protein kinase C activation fail to initiate T cell proliferation in the absence of a costimulatory signal.
Mueller DL; Jenkins MK; Chiodetti L; Schwartz RH
J Immunol; 1990 May; 144(10):3701-9. PubMed ID: 1970590
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of gamma and delta T cell antigen receptor gene expression by phorbol esters and Ca2+ ionophores in the acute lymphocyte leukemia DND41 cell line.
Martinez-Valdez H; Takihara Y; Champagne E; Minden M; Mak TW; Cohen A
Eur J Immunol; 1991 Oct; 21(10):2625-8. PubMed ID: 1833206
[TBL] [Abstract][Full Text] [Related]
14. Signaling via the inositol phospholipid pathway by T cell antigen receptor is limited by receptor number.
Graber M; Bockenstedt LK; Weiss A
J Immunol; 1991 May; 146(9):2935-43. PubMed ID: 1826700
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
[TBL] [Abstract][Full Text] [Related]
16. Modulation of protein kinase C-epsilon by phorbol esters in the monoblastoid U937 cell.
Ways DK; Messer BR; Garris TO; Qin W; Cook PP; Parker PJ
Cancer Res; 1992 Oct; 52(20):5604-9. PubMed ID: 1394183
[TBL] [Abstract][Full Text] [Related]
17. Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1.
Tuttle TM; Inge TH; Bethke KP; McCrady CW; Pettit GR; Bear HD
Cancer Res; 1992 Feb; 52(3):548-53. PubMed ID: 1732041
[TBL] [Abstract][Full Text] [Related]
18. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Hess AD; Bright EC
Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of IL2 production impairment by lipoxygenase inhibitors in activated Jurkat cells.
Dornand J; Gerber M
J Lipid Mediat; 1991; 4(1):23-38. PubMed ID: 1832571
[TBL] [Abstract][Full Text] [Related]
20. The presence in a mouse T cell line of a 97-kDa protein kinase C (PKC) with characteristics similar to known members of the novel PKC subgroup and its possible role in lymphocyte gene expression.
Simek SL; Fields AP; Colburn NH; Winkler-Pickett R; Young HA
J Immunol; 1992 Dec; 149(11):3542-9. PubMed ID: 1431124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
